Background: Attainment of therapeutic goals in Type 2 Diabetes Mellitus (T2DM) necessitates the rational use of drugs, given the wide options available and the presence of co-morbid diseases. Objec
Minimal, de-identified, aggregated data for baseline characteristics and plots of propensity score density and cumulative incidence of butalbital prescription and medication overuse headache. Outcome